The relationship between ABO blood and EGFR mutations in lung adenocarcinoma is still unclear. The purpose of this study was to evaluate the association between ABO blood and EGFR mutations percentage in patients with lung adenocarcinoma. Subject and method: A cross-sectional descriptive study, 276 lung adenocarcinoma patients were tested for EGFR mutations and ABO blood from January 2020 to April 2023.

Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer. Assessed the level of mRNA expression of CIZ1b, VEGF, EGFR mutations and the rate of Merkel cell infection in patients with non-small cell lung cancer.

To describe the clinical and subclinical features of lung cancer patients with EGFR mutations before TKIs therapy and in the relapsed period. To identify the T790M mutation and MET amplification in patients with lung cancer and EGFR-TKIs resistance and the relationship with clinical and subclinical features.

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma